Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 335.66x is 345% above its 1-year average of 75.37x, near the high end of its 1-year range (-55.60x–335.66x).
As of the fiscal period ended Friday, June 30, 2023.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2023 (2023-06-30): 335.66x.
INTEREST COVERAGE RATIO
335.66x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 457 covered companies
CURRENT VS SECTOR MEDIAN
+6051.49%
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$474.21M
Interest Coverage Ratio
335.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.58M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.52M
Interest Coverage Ratio
30.36x
TTM Avg
30.37x
3Y Avg
18.36x
5Y Avg
29.15x
Market Cap
$486.52M
Interest Coverage Ratio
5.63x
TTM Avg
4.06x
3Y Avg
3.16x
5Y Avg
2.54x
Market Cap
$461.10M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$497.40M
Interest Coverage Ratio
-99.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $474.21M | 335.66x | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.82M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $472.58M | -1.04x | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $472.52M | 30.36x | 30.37x | 18.36x | 29.15x |
| Arvinas, Inc. (ARVN)vs › | $479.39M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.52M | 5.63x | 4.06x | 3.16x | 2.54x |
| NRC Health (NRC)vs › | $461.10M | 4.74x | 9.15x | 25.82x | 26.16x |
| Evolus, Inc. (EOLS)vs › | $490.62M | -1.91x | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $497.40M | -99.49x | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $450.09M | N/A | N/A | N/A | N/A |
Interest Coverage
335.7x
Debt/Equity
0.03
Current Ratio
37.17
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-06-30 | 335.66x |
| 2023-03-31 | -55.60x |
| 2022-12-31 | -53.95x |
